Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Parotid salivary duct carcinoma: A single institution’s 20-year experience

European Archives of Oto-Rhino-Laryngology | May 10, 2019 Pharmacology/Therapy

Local control of breast conservation therapy vs mastectomy in multifocal or multicentric breast cancer: A systematic review and meta-analysis

Breast Care | May 10, 2019 Pharmacology/Therapy

Pembrolizumab vs chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial

The Lancet | May 09, 2019 Pharmacology/Therapy

Nurse practitioners and physician assistants: An underestimated workforce for older adults with cancer

Journal of the American Geriatrics Society | May 09, 2019 Pharmacology/Therapy

Adjuvant chemoradiotherapy vs radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis

European Journal of Obstetrics & Gynecology and Reproductive Biology | May 09, 2019 Pharmacology/Therapy

Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States

JAMA Oncology | May 08, 2019 Pharmacology/Therapy

Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: Phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial

The Lancet Haematology | May 08, 2019 Pharmacology/Therapy

Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma

New England Journal of Medicine | May 07, 2019 Pharmacology/Therapy

Phase II study of S-1 and paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

The Oncologist | May 07, 2019 Pharmacology/Therapy

Analysis of DNA damage response gene alterations and tumor mutational burden across 17,486 tubular gastrointestinal carcinomas: Implications for therapy

The Oncologist | May 07, 2019 Pharmacology/Therapy

« Prev 1 … 209 210 211 212 213 … 375 Next »

Parotid salivary duct carcinoma: A single institution’s 20-year experience

Local control of breast conservation therapy vs mastectomy in multifocal or multicentric breast cancer: A systematic review and meta-analysis

Pembrolizumab vs chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial

Nurse practitioners and physician assistants: An underestimated workforce for older adults with cancer

Adjuvant chemoradiotherapy vs radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis

Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States

Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: Phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial

Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma

Phase II study of S-1 and paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Analysis of DNA damage response gene alterations and tumor mutational burden across 17,486 tubular gastrointestinal carcinomas: Implications for therapy

Article on Tirzepatide: Latest Guidelines, Uses, and Clinical Evidence in Obesity and Diabetes Management

MD Clip on How to Assess, Monitor, and Treat Hepatitis B

Article: Cardiovascular Risk in Diabetes: Integrating GLP-1 and SGLT2 Therapy

Understanding your risk: Are women likelier to have thyroid cancer than men are?

Mediterranean diet provides symptom relief for patients with ibs in pilot study

Parotid salivary duct carcinoma: A single institution’s 20-year experience

Local control of breast conservation therapy vs mastectomy in multifocal or multicentric breast cancer: A systematic review and meta-analysis

Pembrolizumab vs chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial

Nurse practitioners and physician assistants: An underestimated workforce for older adults with cancer

Adjuvant chemoradiotherapy vs radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis

Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States

Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: Phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial

Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma

Phase II study of S-1 and paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Analysis of DNA damage response gene alterations and tumor mutational burden across 17,486 tubular gastrointestinal carcinomas: Implications for therapy

Article on Tirzepatide: Latest Guidelines, Uses, and Clinical Evidence in Obesity and Diabetes Management

MD Clip on How to Assess, Monitor, and Treat Hepatitis B

Article: Cardiovascular Risk in Diabetes: Integrating GLP-1 and SGLT2 Therapy

Understanding your risk: Are women likelier to have thyroid cancer than men are?

Mediterranean diet provides symptom relief for patients with ibs in pilot study

Select Specialty

Select Topic